Ascentage Pharma Group International (AAPG) Total Current Liabilities: 2023-2024
Historic Total Current Liabilities for Ascentage Pharma Group International (AAPG) over the last 2 years, with Dec 2024 value amounting to $159.8 million.
- Ascentage Pharma Group International's Total Current Liabilities was N/A to $171.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $171.3 million, marking a year-over-year change of. This contributed to the annual value of $159.8 million for FY2024, which is 20.91% up from last year.
- Latest data reveals that Ascentage Pharma Group International reported Total Current Liabilities of $159.8 million as of FY2024, which was up 20.91% from $132.2 million recorded in FY2023.
- Over the past 5 years, Ascentage Pharma Group International's Total Current Liabilities peaked at $159.8 million during FY2024, and registered a low of $132.2 million during FY2023.
- Over the past 2 years, Ascentage Pharma Group International's median Total Current Liabilities value was $146.0 million (recorded in 2023), while the average stood at $146.0 million.
- Data for Ascentage Pharma Group International's Total Current Liabilities shows a peak YoY rose of 20.91% (in 2024) over the last 5 years.
- Ascentage Pharma Group International's Total Current Liabilities (Yearly) stood at $132.2 million in 2023, then climbed by 20.91% to $159.8 million in 2024.